We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+10.55%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$3.14B
AUM Growth
+$728M
Cap. Flow
+$534M
Cap. Flow %
17.01%
Top 10 Hldgs %
37.86%
Holding
6,828
New
511
Increased
3,030
Reduced
2,253
Closed
625

Sector Composition

Rank Sector Weight
1 Technology 21.21%
2 Consumer Discretionary 7.37%
3 Financials 6.36%
4 Healthcare 5.92%
5 Industrials 5.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SUAC
6526
DELISTED
ShoulderUp Technology Acquisition Corp.
SUAC
$0 ﹤0.01%
10
NIMC
6527
DELISTED
NiSource Inc. Series A Corporate Units
NIMC
-43
Closed -$4K
PTRS
6528
DELISTED
Partners Bancorp Common Stock
PTRS
-1,348
Closed -$12K
APGB
6529
DELISTED
Apollo Strategic Growth Capital II
APGB
-372
Closed -$4K
ZIVO
6530
DELISTED
Zivo Bioscience, Inc. Common Stock
ZIVO
$0 ﹤0.01%
+4
New +$74
AGILW
6531
DELISTED
AgileThought Inc Warrant
AGILW
$0 ﹤0.01%
1
MTRY
6532
DELISTED
Monterey Innovation Acquisition Corp. Common Stock
MTRY
$0 ﹤0.01%
16
SHUAU
6533
DELISTED
SHUAA Partners Acquisition Corp I Unit
SHUAU
$0 ﹤0.01%
11
ALOR
6534
DELISTED
ALSP Orchid Acquisition Corp I
ALOR
$0 ﹤0.01%
30
-123
-80% -$1.27K
CANO.WS
6535
DELISTED
Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150
CANO.WS
$0 ﹤0.01%
104
APRN
6536
DELISTED
Blue Apron Holdings, Inc. Class A Common Stock
APRN
$0 ﹤0.01%
8
-1,046
-99% -$11.5K
INDIW
6537
DELISTED
indie Semiconductor, Inc. Warrant
INDIW
$0 ﹤0.01%
5
DKDCU
6538
DELISTED
Data Knights Acquisition Corp. Unit
DKDCU
-1
Closed
JPT
6539
DELISTED
Nuveen Preferred and Income Fund
JPT
-200
Closed -$4K
BODY.WS
6540
DELISTED
The Beachbody Company, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
BODY.WS
$0 ﹤0.01%
37
EGLX
6541
DELISTED
Enthusiast Gaming Holdings Inc. Common Stock
EGLX
-5,041
Closed -$3K
LTRPB
6542
DELISTED
Liberty TripAdvisor Holdings, Inc. Series B
LTRPB
-43
Closed -$1K
SFRWW
6543
DELISTED
Appreciate Holdings, Inc. Warrant
SFRWW
$0 ﹤0.01%
46
SKIL.WS
6544
DELISTED
Skillsoft Corp. Warrants, each whole warrant is exercisable for 1/20th of a share of Class A Common Stock at an exercise price of $230.00
SKIL.WS
$0 ﹤0.01%
6
SVVC
6545
DELISTED
Firsthand Technology Value Fund, Inc. Common Stock
SVVC
$0 ﹤0.01%
28
-8
-22% -$8
GTH
6546
DELISTED
Genetron Holdings Limited ADS
GTH
$0 ﹤0.01%
11
NBW
6547
DELISTED
Neuberger Berman California Municipal Fund Inc.
NBW
-100
Closed -$1K
CHNA
6548
DELISTED
Loncar China BioPharma ETF
CHNA
$0 ﹤0.01%
2
ALLG.WS
6549
DELISTED
Allego N.V. Warrants
ALLG.WS
$0 ﹤0.01%
121
ZYNE
6550
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$0 ﹤0.01%
84
-14,949
-99% -$7.88K

Similar funds

Tower Research Capital (TRC)'s Q1 2023 Portfolio in Review

As of Q1 2023, Tower Research Capital (TRC) held 6,828 positions worth $3.14B, up 30% from $2.41B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Tower Research Capital (TRC) deployed $534M of net new capital in Q1 2023, opening 511 new positions and adding to 3,030 existing holdings. Its largest new stake was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $52.8M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2023 buy was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $52.8M.
  • Tower Research Capital (TRC) fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $7.26M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 38% of its $3.14B portfolio in Q1 2023.
  • Tower Research Capital (TRC) opened 511 new positions and closed 625 in Q1 2023.
  • Tower Research Capital (TRC)'s portfolio value rose 30% quarter-over-quarter to $3.14B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.